Evidence map›Paper›PMID 33051968›Full record

ArticleAmerican journal of medical genetics. Part A2021

Rapid deployment of a telemedicine care model for genetics and metabolism during COVID-19.

Natasha Shur, Shireen M Atabaki, Monisha S Kisling, Abir Tabarani, Clarence Williams, Jamie L Fraser, Debra S Regier, Marshall Summar, Rare Disease Institute

Abstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Family perception of a telehealth program for people with cystic fibrosis during the COVID-19 pandemic in northeastern Brazil.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2023
    Article
  8. Newborn Screening in a Pandemic-Lessons Learned.International journal of neonatal screening · 2023
    Review
  9. Perspectives on the future of dysmorphology.American journal of medical genetics. Part A · 2023
    Article
  10. Article
  11. Review
  12. Epidemiology of 30,000 Pediatric Urgent Care Telemedicine Visits in the Era of COVID-19.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Natasha ShurChildren's National Hospital, Washington, District of Columbia, USA.ORCID 0000-0003-1336-747X
Shireen M AtabakiChildren's National Hospital, Washington, District of Columbia, USA.
Monisha S KislingChildren's National Hospital, Washington, District of Columbia, USA.
Abir TabaraniChildren's National Hospital, Washington, District of Columbia, USA.
Clarence WilliamsChildren's National Hospital, Washington, District of Columbia, USA.
Jamie L FraserChildren's National Hospital, Washington, District of Columbia, USA.
Debra S RegierChildren's National Hospital, Washington, District of Columbia, USA.
Marshall SummarChildren's National Hospital, Washington, District of Columbia, USA.
Rare Disease Institute

Funding

BlueCross BlueShield CareFirst FoundationHealth Resources and Services Administration (HRSA) Cooperative Agreement #UH7MC30773 (6/2017-5/2020)Unrestricted philanthropic grant from BioMarin (San Rafael, California) and Retrophin Inc
6 · The paper itself

Abstract

The national importance of telemedicine for safe and effective patient care has been highlighted by the current COVID-19 pandemic. Prior to the 2020 pandemic the Division of Genetics and Metabolism piloted a telemedicine program focused on initial and follow-up visits in the patients' home. The goals were to increase access to care, decrease missed work, improve scheduling, and avoid the transport and exposure of medically fragile patients. Visits were conducted by physician medical geneticists, genetic counselors, and biochemical dietitians, together and separately. This allowed the program to develop detailed standard operating procedures. At the onset of the COVID-19 pandemic, this pilot-program was deployed by the full team of 22 providers in one business day. Two physicians remained on-site for patients requiring in-person evaluations. This model optimized patient safety and workforce preservation while providing full access to patients during a pandemic. We provide initial data on visit numbers, types of diagnoses, and no-show rates. Experience in this implementation before and during the pandemic has confirmed the effectiveness and value of telemedicine for a highly complex medical population. This program is a model that can and will be continued well-beyond the current crisis.

Indexed as

Models, OrganizationalPandemicsAdolescentAdultChildChild, PreschoolCOVID-19Delivery of Health CareEndocrinologyFemaleGenetic CounselingGenetic Diseases, InbornGenetics, MedicalGenetic TestingHumansImplementation ScienceCOVID-19geneticspediatricstelemedicine

Identifiers

PMID33051968
PMCPMC7675281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.